Transaction #3106 · Form 4 · 0001521111-25-000003
Nuvation Bio Inc. · Exercise / conversion · Class A Common Stock
Nuvation Bio Inc. · Transacted October 27, 2025 · Filed October 29, 2025
What does this filing report?
An SEC Form 4 filing for Nuvation Bio Inc. records an exercise / conversion involving Class A Common Stock on October 27, 2025. The reported quantity was 100,000. The filing date is October 29, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Nuvation Bio Inc.
- Company CIK
- 0001811063
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 100,000
- Reported price
- 1.74
- Reference value
- 174,000
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 100,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 29, 2025, 4:24 PM EDT
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Hattersley Gary ↗
CHIEF SCIENTIFIC OFFICER
CIK 0001521111
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Shares sold pursuant to a 10b5-1 plan dated June 24, 2024.
- F2
- Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F3
- Options vest as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.